Mammography SPECT With Rotating Slant Hole Collimator
| Status: | Withdrawn |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 35 - 80 |
| Updated: | 4/17/2018 |
| Start Date: | December 2006 |
| End Date: | December 2007 |
The goal is to conduct a pilot study to determine the feasibility of the clinical use of
RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical
protocol.
RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical
protocol.
The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for
imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The
motivation is the requirement of a low cost RMSSH collimator and a conventional
Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable
for applications in breast imaging.
imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The
motivation is the requirement of a low cost RMSSH collimator and a conventional
Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable
for applications in breast imaging.
Inclusion Criteria:
- Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed
with breast cancer.
Exclusion Criteria:
- Pregnant (or possibly pregnant)
- Lactating
- Unable to give consent
- Weights over 300 pounds
- Women who have already undergone definitive surgical treatment to their breast for
breast cancer will not be eligible.
We found this trial at
1
site
Click here to add this to my saved trials
